
Daniel T. McKillop
Partner
201-896-7115 dmckillop@sh-law.comFirm Insights
Author: Daniel T. McKillop
Date: May 17, 2019
Partner
201-896-7115 dmckillop@sh-law.comThe New Jersey Medicinal Marijuana Program will soon see a slate of changes aimed to expand access to medical cannabis. Of particular interest to cannabis businesses, the regulations adopted by the Department of Health (DOH) allow the agency to create a permit-granting system that divides up the medical marijuana industry between cultivators, manufacturers, and retailers.
Many of the changes were made in response to Executive Order No. 6, in which Gov. Phil Murphy directed the DOH and the Board of Medical Examiners to “undertake a review of all aspects of New Jersey’s medical marijuana program, with a focus on ways to expand access to marijuana for medical purposes.” The program has already expanded significantly since Murphy took office in 2018. The medical marijuana program now has 46,300 patients, 950 doctors and 1,850 caregivers participating.
“These rules solidify key program reforms to ensure greater patient access to this effective therapy,” Health Commissioner Shereef Elnahal said in a press statement. “With these changes, the Department will be able to add conditions more rapidly, remove barriers for minors and increase supply of product available.”
The DOH’s amended medical marijuana rules codify several changes that have already taken effect. They include:
The rule also makes additional changes that will go into effect upon publication, which will be on May 20, 2019. They include:
The DOH rules establish a separate permitting system for cultivation, manufacturing and dispensing marijuana for medical purposes. Going forward, applicants must submit a fee of $20,000 for each endorsement sought in the application. Each endorsement authorizes the following activities:
The new rules also add several additional criteria that the DOH will consider when evaluating permit applications. They include: experience in cultivating, processing, or dispensing marijuana in compliance with government-regulated marijuana programs; history of compliance with regulations and policies governing government-regulated marijuana programs; ability and experience of the applicant in ensuring adequate supply of marijuana; and workforce and job creation plans, including a plan to involve women, minorities, and military veterans in ATC ownership, management, and experience with collective bargaining in the cannabis and other industries.
The expansion of New Jersey’s medical marijuana industry is good news, particularly given that efforts to legalize recreational cannabis are effectively dead. Senate President Stephen Sweeney recently issued the following statement via social media: “We will move forward with the expansion of our medical cannabis program as well as the progressive social justice reforms in the expungement legislation. We will not, however, pursue the legalization of adult use marijuana at this time.”
Although legalization is unlikely in the near term, business opportunities are still available. An estimated 50 to 90 medical marijuana dispensaries will be needed in New Jersey in the next three years to keep up with the Medicinal Marijuana Program’s rapidly expanding patient population, according to a DOH report. The report also revealed that the state’s existing ATCs nearly doubled their revenues from 2017 to 2018, earning $29 million and $53 million respectively.
For entities that are interested in entering the New Jersey medical cannabis industry, there are numerous legal, logistical and operational issues that must be addressed. Prospective ATC applicants should contact a knowledgeable attorney to discuss this process in greater detail.
If you have any questions or if you would like to discuss the matter further, please contact me, Dan McKillop, at 201-806-3364.
This article is a part of a series pertaining to cannabis legalization in New Jersey and the United States at large. Prior articles in this series are below:
Disclaimer: Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy. Legal advice provided by Scarinci Hollenbeck, LLC is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Scarinci Hollenbeck, LLC will not provide assistance in circumventing Federal or state cannabis law or policy, and advice provided by our office should not be construed as such.
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Over the past year, brick-and-mortar stores have closed their doors at a record pace. Fluctuating consumer preferences, the rise of online shopping platforms, and ongoing economic uncertainty continue to put pressure on the retail industry. When a retailer seeks bankruptcy protection, a myriad of other businesses are often impacted. Whether you are a supplier, customer, […]
Author: Brian D. Spector
Since his inauguration two months ago, Donald Trump’s administration and the Congress it controls have indicated important upcoming policy changes. These changes will impact financial services policies and priorities. The changes will particularly affect cryptocurrency, as well as banking rules and regulations. Key Regulatory Changes in Cryptocurrency For example, in the burgeoning cryptocurrency business environment, […]
Author: Dan Brecher
The retail sector has experienced a wave of bankruptcy filings over the last year. Brick-and-mortar businesses in financial distress include big-name brands like Big Lots, Party City, The Container Store, and Vitamin Shoppe. When large retailers seek bankruptcy protection, they are not the only businesses impacted. Landlords can be particularly hard hit. While commercial landlords […]
Author: Brian D. Spector
The bankruptcy legal landscape presents both challenges and opportunities for businesses navigating financial distress. Understanding current bankruptcy trends can help businesses make more informed and strategic decisions. Corporate Bankruptcy Filings Trending Upwards Bankruptcy filings continued to trend upwards in 2024. According to statistics released by the Administrative Office of the U.S. Courts, personal and business […]
Author: Brian D. Spector
In December, the U.S. Securities and Exchange Commission (SEC) announced charges against two privately held companies for failing to file a Form D notice, which is generally utilized for exempt securities offerings. Here, the SEC’s enforcement sends a strong message: compliance with regulatory requirements is not optional and failure to comply can have significant consequences. […]
Author: Kenneth C. Oh
On February 14, 2025, the Office of General Counsel (OGC) of the National Labor Relations Board (NLRB) under Acting General Counsel William B. Cowen issued Memorandum 25-05, “New Process for More Efficient, Effective, Accessible and Transparent Case handling.” The Memorandum rescinds nearly all of the Memoranda issued by his direct predecessor, Jennifer Abruzzo, setting the […]
Author: Matthew F. Mimnaugh
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!